• WCG’s eCOA portfolio and imaging analysis technology from NeuroRx are now part of Clario!

menu-close-icon
Your using an unsupported browser. Please update to a modern browser for a better experience.
Skip to content
Clario Clario
  • Solutions
    • eCOA Clinical Trials
      • eCOA Clinical Trials
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rapid Start
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Artificial Intelligence (AI)

      Discover Clario's AI solutions, where innovation meets expertise. Since 2018, we have revolutionized clinical trial endpoint analyses with more than 30 AI-enabled solutions across 600+ active trials, enhancing data quality and patient privacy while expediting data collection processes.

      Go to page
    • Cardiac Solutions
      • Cardiac Solutions
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • Image Redact AI
      • Imaging Platform
      • Modalities
      • SMART Submit
    • Precision Motion
      • Precision Motion for Clinical Trials
      • Precision Motion for Research
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Site-Based Spirometry (FEV1, FVC, PEF, and more.)
      • Virtual Home Spirometry
      • Cough and Lung Sounds
      • Diffusing Capacity (DLCO)
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Eligibility Solution
      • Reporting & Analytics
      • Source Document Manager
    • Decentralized Trials

      All the precision endpoint technology and services your virtual or hybrid trial needs to deliver more certain outcomes.

      Go to page
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Neuroscience
    • Dermatology
    • Oncology
    • Gastroenterology
    • Ophthalmology
    • Hepatology
    • Respiratory Solutions
    • Infectious Diseases
    • Type 2 Diabetes and Obesity
    • Musculoskeletal
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Careers
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Newsroom
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Solutions
    • eCOA Clinical Trials
      • eCOA Clinical Trials
      • eCOA Live
      • eCOA Multimedia
      • eCOA Rapid Start
      • eCOA Rater and Participant Training
      • eCOA Rescue Studies
      • Suicidal Ideation
    • Artificial Intelligence (AI)
    • Cardiac Solutions
      • Cardiac Solutions
      • Arrhythmia Analysis
      • Blood Pressure Services
      • ECG — On-site to DCT and Phase I-IV
      • Phase I/TQT Cardiac Assessment
      • Regulatory Consultation and Statistical Analysis Expertise
    • Medical Imaging
      • Medical Imaging
      • Medical Imaging science team
      • Image Redact AI
      • Imaging Platform
      • Modalities
      • SMART Submit
    • Precision Motion
      • Precision Motion for Clinical Trials
      • Precision Motion for Research
      • Precision Motion: Scientific Publications
    • Respiratory Solutions
      • Respiratory Solutions
      • Site-Based Spirometry (FEV1, FVC, PEF, and more.)
      • Virtual Home Spirometry
      • Cough and Lung Sounds
      • Diffusing Capacity (DLCO)
    • Trial Enablement
      • Trial Enablement
      • Clinical Adjudication
      • Eligibility Solution
      • Reporting & Analytics
      • Source Document Manager
    • Decentralized Trials
      • Decentralized Trials
  • Therapeutic Areas
    • Cardiovascular & Metabolic
    • Dermatology
    • Gastroenterology
    • Hepatology
    • Infectious Diseases
    • Musculoskeletal
    • Neuroscience
    • Oncology
    • Ophthalmology
    • Type 2 Diabetes and Obesity
    • Respiratory Solutions
  • Resources
    • Blog Articles
    • Case Studies
    • Downloads
    • Events
    • External Publications
    • Webinars
  • About
    • The Clario Story
    • Corporate & Social Responsibility
    • Information Security
    • Leadership
    • Legal & Privacy
    • Scientific Expertise
    • Strategic Partnerships
    • Values & Culture
  • Support
    • Customer Support
    • In-Country Cardiac Safety Support
  • Careers
    • Life at Clario
  • Newsroom
  • Login
  • Contact sales
    • Log in
    • Contact sales
  1. Home About Newsroom Clario Teams with WeWork to Enhance Hybrid Work Strategy

Clario Teams with WeWork to Enhance Hybrid Work Strategy

Flexible Workspace to be Accessible for Thousands of Employees Worldwide

Collaboration with WeWork to support a more distributed, inclusive workforce

PHILADELPHIA, PA and NEW YORK, NY February 22, 2023 – Clario, a leading healthcare research and technology company that generates the richest clinical evidence for pharmaceutical, biotech and medical device partners, and WeWork (NYSE: WE), a leading flexible space provider, have partnered to provide Clario’s workforce with WeWork All Access passes and flexible space across the United States, United Kingdom, Germany, Belgium, Hungary, and Costa Rica, giving colleagues even more flexibility with where they work.

COVID changed how and where Clario’s colleagues wanted to engage with each other, and it became clear that Clario needed to balance different needs for different people. Engaging with WeWork, Clario designed a solution that offers a balance between fixed, flexible and remote working.

Combining two WeWork solutions – All Access and private space – Clario’s people will now have access to inspiring workspaces designed for heads-down work or collaborative meetings. Clario’s space will include common areas and shared spaces within the building, including lounge spaces, reading nooks, phone booths for private calls, conference rooms and more. Hybrid working gives individuals and teams at Clario the ability to shape their own work schedules based on their location, workflow and what suits them best on a particular day.

WeWork provides a one-stop solution for enterprise companies looking to adapt their real estate portfolio and update their workplace strategy to meet the dynamic needs of today. WeWork’s streamlined global space-as-a-solution platform reduces the complexity of leasing real estate, allowing companies to focus on what matters most: providing employees with the flexibility to enjoy an exceptional workplace experience on their schedule.

“Our work with Clario is indicative of the demand for flexibility that companies look for when planning the future of their business. Clario is leading the way in embracing a forward-thinking workplace strategy defined by flexibility and collaboration that complements their plans for innovation alongside their talent attraction and retention needs. We are excited to welcome Clario to the WeWork community globally with a workspace that is primed for collaboration and connection as they look to support employees with a new way of working,” said Melinda Holland, COO, Americas at WeWork.

“At Clario we believe our people are our most material differentiator. They define who we are and how we compete in the marketplace. Part of attracting and ultimately retaining talent like ours is to ensure we listen to what people value most. We have learned from countless surveys and feedback sessions that people want flexibility. They want time back, to better balance their personal and professional lives. How work is done has been changed by ever advancing technology and where work needs to be done has forever changed. Working with WeWork has allowed us flexibility to chose locations that fit our employee base. It has reduced travel time, improved work efficiency and allowed our employees and Clario as a company greater overall flexibility. This partnership is one that we are truly excited about and look forward to the future,” said David E. Fusco, EVP, Chief Human Capital Officer at Clario.


About Clario

Clario is a leading technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allow our partners to transform lives. Clario’s Trial Anywhere™ solutions have been powering hybrid and decentralized clinical trials (DCT) for over 20 years, enabling sponsors to collect high-quality endpoint data from any modality or location, all while improving patient experience and diversity. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion and respiratory endpoints. With 30 facilities in nine countries, Clario’s global team of science, technology and operational experts has helped deliver over 19,000 trials and 870 regulatory for over 5m patients in 120 countries. Our innovation has been transforming clinical trials for 50 years. 

For more information, go to Clario.com or follow us on LinkedIn and Twitter.

About WeWork

WeWork (NYSE: WE) was founded in 2010 with the vision to create environments where people and companies come together and do their best work. Since then, we’ve become one of the leading global flexible space providers committed to delivering technology-driven turnkey solutions, flexible spaces, and community experiences. For more information about WeWork, please visit us at wework.com.

Examples:

  • Boston Consulting Group: Boston Consulting Group Opens First-Ever Office in Nashville at WeWork
  • Revolut: Revolut becomes WeWork’s first enterprise member to sign new space using cryptocurrency
  • Goldman Sachs: Goldman Sachs to take space with WeWork in Birmingham
Back to newsroom
Share
Twitter Facebook LinkedIn

Related News

See all news

Clario Announces Completion of Acquisition of WCG’s eCOA Business

May 6, 2025 Read more

Clario collaborates with AWS to push new boundaries in clinical data analysis with generative AI 

April 16, 2025 Read more

Clario announces acquisition of imaging provider NeuroRx

March 17, 2025 Read more
Clario logo
    • Solutions
    • Therapeutic Areas
    • About
    • Resources
    • Careers
    • Newsroom
  • Get in touch

    • Contact
    • Support
    • Customer portal

Follow us

Twitter LinkedIn Glassdoor
×

Contact sales

If you are looking for a partner to help you generate the richest clinical evidence with the right clinical trial technology, please fill in the form below.


Not what you're looking for?

Please visit our Contact Page for customer support, office locations, or media contacts.

  • © 2025 Clario

    • Legal and Privacy Terms
    • Information Security
    • Cookie Policy
    • Impressum